Inhaled fluticasone furoate falls flat in speeding up COVID-19 recovery, says ACTIV-6 trial

The Eu­ro­pean Med­i­cines Agency has flipped its stance on Ei­sai and Bio­gen’s Alzheimer’s treat­ment Leqem­bi, rec­om­mend­ing au­tho­riza­tion in a nar­row­er pop­u­la­tion than it pre­vi­ous­ly con­sid­ered

Manufacturing capacity, safety and increasing costs are among the main concerns for drug manufacturers and CMOs. These crucial elements are also driving development within the

What caused acute vertigo in two healthy women? That’s the diagnostic challenge described by David Elisha, BS, of Tel Aviv University School of Medicine in